Extended-Release Methylphenidate Oral Tablets Extended-Release Methylphenidate Oral Tablets
A newly approved extended-release formulation of methylphenidate may be another option for the management of ADHD in children.Pediatric Pharmacotherapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 5, 2017 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news
Suicide risk reduction in youths with attention-deficit/hyperactivity disorder prescribed methylphenidate: a Taiwan nationwide population-based cohort study - Liang SH, Yang YH, Kuo TY, Liao YT, Lin TC, Lee Y, McIntyre RS, Kelsen BA, Wang TN, Chen VC.
BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) youths have increased suicide risk. Nevertheless, the beneficial effects of methylphenidate (MPH) on suicide attempt have received relatively little attention. AIMS: To investigate the MPH usage a... (Source: SafetyLit)
Source: SafetyLit - November 13, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
‘Relative’ school age biases ADHD diagnosis
Study suggests over-diagnosis in youngest Related items fromOnMedica Doctors should exercise caution in prescribing Ritalin for ADHD Attention deficit hyperactivity disorder (ADHD) New treatment options for ADHD Unhealthy diet during pregnancy may be linked to ADHD UK drug treatment of ADHD in children may have peaked (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 10, 2017 Category: UK Health Source Type: news
Stimulant Cuts Apathy, Improves Cognition in Mild Alzheimer's Stimulant Cuts Apathy, Improves Cognition in Mild Alzheimer's
Improved cognition among older veterans with mild Alzheimer ' s disease taking methylphenidate was somewhat unexpected.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 3, 2017 Category: Consumer Health News Tags: Psychiatry News Source Type: news
Jimmy Kimmel Thinks ‘Donald Trump Has More Flip-Flops Than a Jimmy Buffett Concert’ So He Made a Supercut
Following the death of the Graham-Cassidy bill — the latest Senate attempt to repeal Obamacare — Jimmy Kimmel took to the Live! stage to express his relief that the proposal wouldn’t pass.
Senate Majority Leader Mitch McConnell announced Tuesday that the Senate would not vote on Graham-Cassidy in the wake of Senators Susan Collins and John McCain declaring their opposition to it. However, the latter’s decision drew some blowback from President Donald Trump, who tweeted in criticism of McCain reversing his position on Obamacare — a stance that Kimmel found hypocritical.
“The President had...
Source: TIME.com: Top Science and Health Stories - September 27, 2017 Category: Consumer Health News Authors: Megan McCluskey Tags: Uncategorized Donald Trump Health Care Jimmy Kimmel jimmy kimmel live Late Night Television politics TV Source Type: news
Most alternative therapies for treating autism show, at best, inconclusive benefits
Dr. Shafali Jeste knows well the desperation of a parent seeking a cure for their child with autism spectrum disorder. As a clinician who both researches the causes of the disorder and treats children with autism, Jeste, UCLA associate professor of psychiatry, neurology and pediatrics and a lead investigator in the UCLA Center for Autism Research and Treatment, understands why many parents will try anything that sounds reasonable. A change to a gluten- and casein-free diet to reduce symptoms. Mega-vitamins for the same. Medical marijuana to calm. Melatonin to sleep. Omega-3 fatty acids for hyperactivity. Delaying or refusi...
Source: UCLA Newsroom: Health Sciences - September 26, 2017 Category: Universities & Medical Training Source Type: news
New delayed-release stimulant improves morning ADHD symptoms and all-day functioning
(Mary Ann Liebert, Inc./Genetic Engineering News) A phase 3 study of children ages 6-12 years with attention deficit/hyperactivity disorder (ADHD) has shown that a delayed-release, long-acting formulation of the stimulant methylphenidate, when taken in the evening, led to significant improvement in ADHD symptoms and functional impairment first thing the next morning, compared to a placebo. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 25, 2017 Category: International Medicine & Public Health Source Type: news
A naturalistic comparison of methylphenidate and risperidone monotherapy in drug-naive youth with attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder and aggression - Masi G, Manfredi A, Nieri G, Muratori P, Pfanner C, Milone A.
BACKGROUND/PURPOSE: Attention-deficit/hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD) are frequently co-occurring in youth, but data about the pharmacological management of this comorbidity are scarce, especially when impulsive aggres... (Source: SafetyLit)
Source: SafetyLit - August 25, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
methylphenidate hydrochloride (Quillivant XR)
Title: methylphenidate hydrochloride (Quillivant XR)Category: MedicationsCreated: 7/24/2014 12:00:00 AMLast Editorial Review: 8/8/2017 12:00:00 AM (Source: MedicineNet Kids Health General)
Source: MedicineNet Kids Health General - August 8, 2017 Category: Pediatrics Source Type: news
Adderall vs. Ritalin (Differences and Similarities)
Title: Adderall vs. Ritalin (Differences and Similarities)Category: MedicationsCreated: 8/7/2017 12:00:00 AMLast Editorial Review: 8/7/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - August 7, 2017 Category: Drugs & Pharmacology Source Type: news
Association of risk of suicide attempts with methylphenidate treatment - Man KKC, Coghill D, Chan EW, Lau WCY, Hollis C, Liddle E, Banaschewski T, McCarthy S, Neubert A, Sayal K, Ip P, Schuemie MJ, Sturkenboom MCJM, Sonuga-Barke E, Buitelaar J, Carucci S, Zuddas A, Kovshoff H, Garas P, Nagy P, Inglis SK, Konrad K, H äge A, Rosenthal E, Wong ICK.
IMPORTANCE: Patients with attention-deficit/hyperactivity disorder (ADHD) are at an increased risk of attempting suicide. Stimulants, such as methylphenidate hydrochloride, are the most common treatment for ADHD, but the association between their therapeut... (Source: SafetyLit)
Source: SafetyLit - July 29, 2017 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Methylphenidate-Suicide Link Doesn't Appear Causal (FREE)
By Amy Orciari Herman
Edited by Susan Sadoughi, MD
Any link between the ADHD drug methylphenidate and suicide attempts does not appear to be causal, according to an observational study in JAMA Psychiatry.Using a … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - July 27, 2017 Category: Primary Care Source Type: news
Treating ADHD May Help Curb Addiction Problems
For people with the disorder, meds like Ritalin linked to lower rates of alcohol, drug abuse, study finds (Source: WebMD Health)
Source: WebMD Health - July 24, 2017 Category: Consumer Health News Source Type: news
Cotempla XR ODT (Methylphenidate Extended-Release Orally Disintegrating Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 29, 2017 Category: Drugs & Pharmacology Source Type: news
Methylphenidate disintegration from oral formulations for intravenous use by experienced substance users - Bjarnadottir GD, Johannsson M, Magnusson A, Rafnar BO, Sigurdsson E, Steingrimsson S, Asgrimsson V, Snorradottir I, Bragadottir H, Haraldsson HM.
BACKGROUND AND AIMS: Methylphenidate (MPH) is a prescription stimulant used to treat attention-deficit hyperactivity disorder. MPH is currently the preferred substance among most intravenous (i.v.) substance users in Iceland. Four types of MPH preparations... (Source: SafetyLit)
Source: SafetyLit - June 28, 2017 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
